Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 2/20 | 0.44 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.44 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.44 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.44 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | CCR5 | P51681 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7758338 | 0.88 | PTGER1 (0.46) | PTGER1PTGER4PTGER3PTGER2MTNR1A | |
| SCHEMBL724228 | 0.85 | PTGER1 (0.55) | PTGER1PTGER4PTGER3PTGER2MTNR1A | |
| Hydrochloric Acid SCHEMBL723195 | 0.85 | PTGER1 (0.54) | PTGER1PTGER4PTGER3PTGER2MTNR1A | |
| SCHEMBL4659041 | 0.85 | CHRM2 (0.39) | PTGER1PTGER4PTGER3PTGER2 | |
| SCHEMBL11299423 | 0.83 | MAOA (0.44) | PTGER1PTGER4PTGER3PTGER2MTNR1A | |
| SCHEMBL1158253 | 0.83 | CHRM2 (0.45) | MTNR1BDRD2 | |
| SCHEMBL1901763 | 0.83 | PTGER1 (0.47) | PTGER1PTGER4PTGER3PTGER2MTNR1A | |
| Hydrochloric Acid SCHEMBL16166428 | 0.82 | CHRM2 (0.45) | MTNR1BDRD2 | |
| SCHEMBL724160 | 0.81 | HTR1A (0.39) | PTGER1PTGER4PTGER3PTGER2ABCB1 | |
| SCHEMBL722594 | 0.81 | IGF1R (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012098560-A2 | PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST | MSN LABORATORIES LIMITED (IN) | 2012-07-26 | — | — | WO | claimed |
| WO-2012025941-A2 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | CADILA HEALTHCARE LIMITED (IN) | 2012-03-01 | — | — | WO | claimed |
| WO-2009037569-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF FESOTERODINE | ACTAVIS GROUP PTC EHF (IS) | 2009-03-26 | — | — | WO | claimed |
| EP-2800735-A2 | PROCESS FOR THE PREPARATION OF FESOTERODINE | Alembic Pharmaceuticals Limited (IN) | 2014-11-12 | — | — | EP | disclosed |
| EP-2780317-A2 | THE NOVEL REFERENCE MARKERS FOR FESOTERODINE FUMARATE | Alembic Pharmaceuticals Limited (IN) | 2014-09-24 | — | — | EP | disclosed |
| WO-2013046194-A2 | THE NOVEL REFERENCE MARKERS FOR FESOTERODINE FUMARATE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2013-04-04 | — | — | WO | disclosed |
| WO-2013035084-A2 | PROCESS FOR THE PREPARATION OF FESOTERODINE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2013-03-14 | — | — | WO | disclosed |
| WO-2012098560-A2 | PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST | MSN LABORATORIES LIMITED (IN) | 2012-07-26 | — | — | WO | disclosed |
| WO-2012025941-A2 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | CADILA HEALTHCARE LIMITED (IN) | 2012-03-01 | — | — | WO | disclosed |
| WO-2011141932-A2 | PROCESS FOR PREPARATION OF PHENOLIC MONOESTERS OF HYDROXYMETHYL PHENOLS | INTAS PHARMACEUTICALS LIMITED (IN) | 2011-11-17 | — | — | WO | disclosed |
| EP-2323967-A2 | FESOTERODINE COMPRISING A REDUCED AMOUNT OF DEHYDROXYFESOTERODINE | Actavis Group PTC EHF (IS) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010010464-A2 | FESOTERODINE SUBSTANTIALLY FREE OF DEHYDROXY IMPURITY | ACTAVIS GROUP PTC EHF (IS) | 2010-01-28 | — | — | WO | disclosed |
| WO-2009037569-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF FESOTERODINE | ACTAVIS GROUP PTC EHF (IS) | 2009-03-26 | — | — | WO | disclosed |
| EP-1940774-A1 | NEW SYNTHESIS OF SUBSTITUTED HYDROXYMETHYL PHENOLS | Schwarz Pharma Ltd. (IE) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007137799-A1 | NEW SYNTHESIS OF SUBSTITUTED HYDROXYMETHYL PHENOLS | SCHWARZ PHARMA LTD. (IE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2005012227-A2 | PROCESS FOR PREPARATION OF 2-(3-DIISOPROPYLAMINO-1-PHENYLPROPYL)-4-HYDROXYMETHYL-PHENOL, A METABOLITE OF TOLTERODINE | RANBAXY LABORATORIES LIMITED (IN) | 2005-02-10 | — | — | WO | disclosed |
| EP-1230209-A2 | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | SCHWARZ PHARMA AG (DE) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001035957-A1 | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | SANOL ARZNEI SCHWARZ GMBH (DE) | 2001-05-25 | — | — | WO | disclosed |